SASSINE ANDY
SEC insider (Form 3/4/5 filer). CIK 0001515322. Chief Financial Officer at Arcturus Therapeutics Holdings Inc. (ARCT) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 15, 2025. Located in NASHUA, NH.
Companies SASSINE ANDY has filed insider reports for
- Arcturus Therapeutics Holdings Inc. (ARCT): Director, Officer, Chief Financial Officer
- ICAD INC (ICAD): Director
SASSINE ANDY
CIK: 0001515322
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 15, 2025ARCT
Arcturus Therapeutics Holdings Inc.
PurchaseDirect1.2K shares at avg. $16.56$20K - Jul 17, 2025ICAD
ICAD INC
DispositionDirect1.2M shares- - Jan 3, 2025ICAD
ICAD INC
AwardDirectDirector Stock Option (right to buy)
30K shares- - Dec 16, 2024ARCT
Arcturus Therapeutics Holdings Inc.
AwardDirectEmployee Stock Option (right to buy)
60K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 15, 2025 |  ARCT Arcturus Therapeutics Holdings Inc. | Purchase | 1,238 | $16.56 | $20,499 | Direct |
| Jul 17, 2025 |  ICAD ICAD INC | Disposition | 1,198,382 | - | - | Direct |
| Jan 3, 2025 | ICAD ICAD INC | Award Director Stock Option (right to buy) | 30,000 | - | - | Direct |
| Dec 16, 2024 | ARCT Arcturus Therapeutics Holdings Inc. | Award Employee Stock Option (right to buy) | 60,000 | - | - | Direct |
1-4 of 4 transactions